Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional surveyopen access
- Authors
- Noh, Y.[Noh, Y.]; Kim, J.H.[Kim, J.H.]; Yoon, D.[Yoon, D.]; Choe, Y.J.[Choe, Y.J.]; Choe, S.-A.[Choe, S.-A.]; Jung, J.[Jung, J.]; Lee, S.-W.[Lee, S.-W.]; Shin, J.-Y.[Shin, J.-Y.]
- Issue Date
- 22-Jul-2022
- Publisher
- Korean Society of Epidemiology
- Keywords
- Coronavirus; Immunization; Public health; Vaccine hesitancy
- Citation
- Epidemiology and Health, v.44
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- Epidemiology and Health
- Volume
- 44
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/105503
- DOI
- 10.4178/epih.e2022061
- ISSN
- 1225-3596
- Abstract
- OBJECTIVES: This study explored predictors of coronavirus disease 2019 (COVID-19) booster hesitancy among fully vaccinated young adults and parental COVID-19 vaccine hesitancy for their children. METHODS: This cross-sectional study administered an online survey from December 2 to December 20, 2021. We enrolled participants aged 18-49 years, for whom ≥ 2 weeks had passed after their initial COVID-19 vaccination. We estimated odds ratios (ORs) with 95% confidence intervals (CIs) using multivariate logistic regression to evaluate factors associated with booster/ vaccine hesitancy. RESULTS: Among the 2,993 participants, 48.8% showed hesitancy (wait and see: 40.2%; definitely not: 8.7%). Booster hesitancy was more common among women (OR, 1.25; 95% CI, 1.05 to 1.50), younger people (OR, 1.44; 95% CI, 1.17 to 1.77), those with a lower education level (OR, 2.05; 95% CI, 1.10 to 3.82), those who received the mRNA-1273 vaccine type (OR, 2.01; 95% CI, 1.65 to 2.45), and those who experienced serious adverse events following previous COVID-19 vaccination (OR, 2.03; 95% CI, 1.47 to 2.80). The main reasons for booster hesitancy were concerns about safety (54.1%) and doubts about efficacy (29.8%). Among the 1,020 respondents with children aged < 18 years, 65.8% were hesitant to vaccinate their children against COVID-19; hesitancy was associated with younger parental age, education level, the type of vaccine the parent received, and a history of COVID-19 infection. CONCLUSIONS: Concerns about the efficacy and safety of COVID-19 vaccines were the major barrier to booster acceptance. The initial COVID-19 vaccine type (mRNA-1273), young age, gender (women), a low education level, and adverse events after the first COVID-19 vaccine were key predictors of booster hesitancy. © 2022, Korean Society of Epidemiology.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Pharmacy > Department of Pharmacy > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.